Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NSE - Delayed Quote INR

DR AGARWALS HEALTH CARE L (AGARWALEYE.NS)

353.60
-11.30
(-3.10%)
At close: May 2 at 3:30:01 PM GMT+5:30
Loading Chart for AGARWALEYE.NS
  • Previous Close 364.90
  • Open 363.05
  • Bid --
  • Ask --
  • Day's Range 351.00 - 368.45
  • 52 Week Range 351.00 - 464.00
  • Volume 471,299
  • Avg. Volume 1,111,482
  • Market Cap (intraday) 111.752B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 127.65
  • EPS (TTM) 2.77
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 474.25

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services. It also sells glasses, lenses, contact lenses, and frames; and eye care-related pharmaceutical products. The company was incorporated in 2010 and is based in Chennai, India.

www.dragarwals.co.in

4,214

Full Time Employees

March 31

Fiscal Year Ends

Recent News: AGARWALEYE.NS

View More

Performance Overview: AGARWALEYE.NS

Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

AGARWALEYE.NS
12.04%
S&P BSE SENSEX (^BSESN)
3.02%

1-Year Return

AGARWALEYE.NS
12.04%
S&P BSE SENSEX (^BSESN)
7.90%

3-Year Return

AGARWALEYE.NS
12.04%
S&P BSE SENSEX (^BSESN)
41.29%

5-Year Return

AGARWALEYE.NS
12.04%
S&P BSE SENSEX (^BSESN)
138.75%

Compare To: AGARWALEYE.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AGARWALEYE.NS

View More

Valuation Measures

Annual
As of 5/2/2025
  • Market Cap

    112.13B

  • Enterprise Value

    117.57B

  • Trailing P/E

    128.62

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.48

  • Price/Book (mrq)

    7.45

  • Enterprise Value/Revenue

    7.85

  • Enterprise Value/EBITDA

    25.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.60%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    16B

  • Net Income Avi to Common (ttm)

    896.41M

  • Diluted EPS (ttm)

    2.77

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.91B

  • Total Debt/Equity (mrq)

    66.39%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: AGARWALEYE.NS

View More

Company Insights: AGARWALEYE.NS

Research Reports: AGARWALEYE.NS

View More

People Also Watch